用于高风险角膜移植的局部塔克罗利斯:一个随机的临床试验
Jun Shimazaki1, Daisuke Tomida2, Yukari Yagi-Yaguchi2
1Department of Ophthalmology, Tokyo Dental College Ichikawa General Hospital, 5-11-13 Sugano, Ichikawa, 272-8513, Chiba, Japan. meishano1@gmail.com.
BMC ophthalmology
|June 12, 2024
概括
局部使用的塔克罗利斯 (TAC) 在高风险的穿透性角膜整形 (PKP) 患者中表现出良好的耐受性. 然而,这项研究没有证明它在预防PKP后免疫排斥方面的有效性.
科学领域:
- 眼科医生 眼科 眼科
- 免疫学 免疫学 免疫学
- 移植 移植 移植 移植
背景情况:
- 角膜移植排斥发生在10-30%的穿透角膜整形 (PKP) 病例中,高风险患者的发病率更高.
- 局部皮质类固醇是标准的,但对于高风险PKP患者可能不足.
- 局部塔克罗利木斯 (TAC) 是一种潜在的替代方案,用于预防角膜移植后的排斥.
研究的目的:
- 在日本的高风险PKP患者中研究局部TAC的疗效和安全性.
- 评估TAC在抑制角膜移植后排斥的潜力.
主要方法:
- 进行了一项单中心,单盲,随机对照试验.
- 高风险的PKP患者在手术后52周接受了0.1%的TAC眼科悬浮剂或人工眼 (AT).
- 所有参与者都接受了标准的皮质类固醇治疗 (贝他美沙,然后是甲醇).
主要成果:
- 没有观察到局部TAC的严重不良影响.
- 在TAC组中没有发生任何排斥事件,而在AT组中只有一个.
- 两组之间在移植清晰度,视力敏度,眼内压力或内皮细胞密度方面没有发现显著差异.
结论:
- 局部0.1% TAC眼科悬浮液在高风险PKP患者中表现出良好的耐受性.
- 该研究未能证明局部TAC在预防该患者群体免疫排斥方面的有效性.
相关概念视频
01:13Randomized Experiments
6.3K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Simple randomization
Simple...
6.3K
01:11Blinding
3.0K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
3.0K